世界の局所トロンビン市場予測 2023年-2029年

【英語タイトル】Global Topical Thrombin Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC01886)・商品コード:LP23DC01886
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥549,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥823,500見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,098,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の局所トロンビン市場」は、過去の販売実績から2022年の世界の局所トロンビンの総販売量を検討し、2023年から2029年の予測される局所トロンビンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の局所トロンビンの市場規模を掲載し、XXX百万米ドル規模の世界の局所トロンビン市場の詳細な分析を提供します。本インサイトレポートは、世界の局所トロンビン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の局所トロンビン市場における各社の独自のポジションをより深く理解するために、局所トロンビン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の局所トロンビン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。局所トロンビンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。局所トロンビンの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。局所トロンビンのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

局所トロンビンの世界主要メーカーとしては、Takeda、 Bayer、 CSL、 Grifols、 GE Healthcare、 Hualan Biological、 Haematologic Technologies、 Pfizer、 Octapharma、 Omrix Biopharmaceuticals、 Shanghai RAASなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の局所トロンビン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では局所トロンビン市場をセグメンテーションし、種類別 (ウシ系、ヒト系、その他)、用途別 (病院、診療所、学術研究機関)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:ウシ系、ヒト系、その他

・用途別区分:病院、診療所、学術研究機関

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界の局所トロンビン市場の10年間の市場状況・展望は?
・世界および地域別に見た局所トロンビン市場成長の要因は何か?
・局所トロンビンの市場機会はエンドマーケットの規模によってどのように変化するのか?
・局所トロンビンのタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:局所トロンビンの年間販売量2018-2029、地域別現状・将来分析
・局所トロンビンの種類別セグメント:ウシ系、ヒト系、その他
・局所トロンビンの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・局所トロンビンの用途別セグメント:病院、診療所、学術研究機関
・局所トロンビンの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の局所トロンビン市場
・企業別のグローバル局所トロンビン市場データ:2018-2023年の年間販売量、市場シェア
・企業別の局所トロンビンの年間売上:2018-2023年の売上、市場シェア
・企業別の局所トロンビン販売価格
・主要企業の局所トロンビン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

局所トロンビンの地域別レビュー
・地域別の局所トロンビン市場規模2018-2023:年間販売量、売上
・主要国別の局所トロンビン市場規模2018-2023:年間販売量、売上
・南北アメリカの局所トロンビン販売の成長
・アジア太平洋の局所トロンビン販売の成長
・ヨーロッパの局所トロンビン販売の成長
・中東・アフリカの局所トロンビン販売の成長

南北アメリカ市場
・南北アメリカの国別の局所トロンビン販売量、売上(2018-2023)
・南北アメリカの局所トロンビンの種類別販売量
・南北アメリカの局所トロンビンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の局所トロンビン販売量、売上(2018-2023)
・アジア太平洋の局所トロンビンの種類別販売量
・アジア太平洋の局所トロンビンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の局所トロンビン販売量、売上(2018-2023)
・ヨーロッパの局所トロンビンの種類別販売量
・ヨーロッパの局所トロンビンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の局所トロンビン販売量、売上(2018-2023)
・中東・アフリカの局所トロンビンの種類別販売量
・中東・アフリカの局所トロンビンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・局所トロンビンの製造コスト構造分析
・局所トロンビンの製造プロセス分析
・局所トロンビンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・局所トロンビンの主要なグローバル販売業者
・局所トロンビンの主要なグローバル顧客

地域別の局所トロンビン市場予測レビュー
・地域別の局所トロンビン市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・局所トロンビンの種類別市場規模予測
・局所トロンビンの用途別市場規模予測

主要企業分析
Takeda、 Bayer、 CSL、 Grifols、 GE Healthcare、 Hualan Biological、 Haematologic Technologies、 Pfizer、 Octapharma、 Omrix Biopharmaceuticals、 Shanghai RAAS
・企業情報
・局所トロンビン製品
・局所トロンビン販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Topical Thrombin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Topical Thrombin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Topical Thrombin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Topical Thrombin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Topical Thrombin players cover Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies, Pfizer and Octapharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Topical Thrombin Industry Forecast” looks at past sales and reviews total world Topical Thrombin sales in 2022, providing a comprehensive analysis by region and market sector of projected Topical Thrombin sales for 2023 through 2029. With Topical Thrombin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topical Thrombin industry.
This Insight Report provides a comprehensive analysis of the global Topical Thrombin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Topical Thrombin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topical Thrombin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topical Thrombin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topical Thrombin.
This report presents a comprehensive overview, market shares, and growth opportunities of Topical Thrombin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Based Bovine
Based Human
Others
Segmentation by application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies
Pfizer
Octapharma
Omrix Biopharmaceuticals
Shanghai RAAS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Topical Thrombin market?
What factors are driving Topical Thrombin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Topical Thrombin market opportunities vary by end market size?
How does Topical Thrombin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Topical Thrombin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Topical Thrombin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Topical Thrombin by Country/Region, 2018, 2022 & 2029
2.2 Topical Thrombin Segment by Type
2.2.1 Based Bovine
2.2.2 Based Human
2.2.3 Others
2.3 Topical Thrombin Sales by Type
2.3.1 Global Topical Thrombin Sales Market Share by Type (2018-2023)
2.3.2 Global Topical Thrombin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Topical Thrombin Sale Price by Type (2018-2023)
2.4 Topical Thrombin Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostics & Clinics
2.4.3 Academic and Research Institute
2.5 Topical Thrombin Sales by Application
2.5.1 Global Topical Thrombin Sale Market Share by Application (2018-2023)
2.5.2 Global Topical Thrombin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Topical Thrombin Sale Price by Application (2018-2023)
3 Global Topical Thrombin by Company
3.1 Global Topical Thrombin Breakdown Data by Company
3.1.1 Global Topical Thrombin Annual Sales by Company (2018-2023)
3.1.2 Global Topical Thrombin Sales Market Share by Company (2018-2023)
3.2 Global Topical Thrombin Annual Revenue by Company (2018-2023)
3.2.1 Global Topical Thrombin Revenue by Company (2018-2023)
3.2.2 Global Topical Thrombin Revenue Market Share by Company (2018-2023)
3.3 Global Topical Thrombin Sale Price by Company
3.4 Key Manufacturers Topical Thrombin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Topical Thrombin Product Location Distribution
3.4.2 Players Topical Thrombin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Topical Thrombin by Geographic Region
4.1 World Historic Topical Thrombin Market Size by Geographic Region (2018-2023)
4.1.1 Global Topical Thrombin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Topical Thrombin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Topical Thrombin Market Size by Country/Region (2018-2023)
4.2.1 Global Topical Thrombin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Topical Thrombin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Topical Thrombin Sales Growth
4.4 APAC Topical Thrombin Sales Growth
4.5 Europe Topical Thrombin Sales Growth
4.6 Middle East & Africa Topical Thrombin Sales Growth
5 Americas
5.1 Americas Topical Thrombin Sales by Country
5.1.1 Americas Topical Thrombin Sales by Country (2018-2023)
5.1.2 Americas Topical Thrombin Revenue by Country (2018-2023)
5.2 Americas Topical Thrombin Sales by Type
5.3 Americas Topical Thrombin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Topical Thrombin Sales by Region
6.1.1 APAC Topical Thrombin Sales by Region (2018-2023)
6.1.2 APAC Topical Thrombin Revenue by Region (2018-2023)
6.2 APAC Topical Thrombin Sales by Type
6.3 APAC Topical Thrombin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Topical Thrombin by Country
7.1.1 Europe Topical Thrombin Sales by Country (2018-2023)
7.1.2 Europe Topical Thrombin Revenue by Country (2018-2023)
7.2 Europe Topical Thrombin Sales by Type
7.3 Europe Topical Thrombin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Topical Thrombin by Country
8.1.1 Middle East & Africa Topical Thrombin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Topical Thrombin Revenue by Country (2018-2023)
8.2 Middle East & Africa Topical Thrombin Sales by Type
8.3 Middle East & Africa Topical Thrombin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Topical Thrombin
10.3 Manufacturing Process Analysis of Topical Thrombin
10.4 Industry Chain Structure of Topical Thrombin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Topical Thrombin Distributors
11.3 Topical Thrombin Customer
12 World Forecast Review for Topical Thrombin by Geographic Region
12.1 Global Topical Thrombin Market Size Forecast by Region
12.1.1 Global Topical Thrombin Forecast by Region (2024-2029)
12.1.2 Global Topical Thrombin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Topical Thrombin Forecast by Type
12.7 Global Topical Thrombin Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Topical Thrombin Product Portfolios and Specifications
13.1.3 Takeda Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Topical Thrombin Product Portfolios and Specifications
13.2.3 Bayer Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 CSL
13.3.1 CSL Company Information
13.3.2 CSL Topical Thrombin Product Portfolios and Specifications
13.3.3 CSL Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CSL Main Business Overview
13.3.5 CSL Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Topical Thrombin Product Portfolios and Specifications
13.4.3 Grifols Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Topical Thrombin Product Portfolios and Specifications
13.5.3 GE Healthcare Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Hualan Biological
13.6.1 Hualan Biological Company Information
13.6.2 Hualan Biological Topical Thrombin Product Portfolios and Specifications
13.6.3 Hualan Biological Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Hualan Biological Main Business Overview
13.6.5 Hualan Biological Latest Developments
13.7 Haematologic Technologies
13.7.1 Haematologic Technologies Company Information
13.7.2 Haematologic Technologies Topical Thrombin Product Portfolios and Specifications
13.7.3 Haematologic Technologies Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Haematologic Technologies Main Business Overview
13.7.5 Haematologic Technologies Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer Topical Thrombin Product Portfolios and Specifications
13.8.3 Pfizer Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Octapharma
13.9.1 Octapharma Company Information
13.9.2 Octapharma Topical Thrombin Product Portfolios and Specifications
13.9.3 Octapharma Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Octapharma Main Business Overview
13.9.5 Octapharma Latest Developments
13.10 Omrix Biopharmaceuticals
13.10.1 Omrix Biopharmaceuticals Company Information
13.10.2 Omrix Biopharmaceuticals Topical Thrombin Product Portfolios and Specifications
13.10.3 Omrix Biopharmaceuticals Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Omrix Biopharmaceuticals Main Business Overview
13.10.5 Omrix Biopharmaceuticals Latest Developments
13.11 Shanghai RAAS
13.11.1 Shanghai RAAS Company Information
13.11.2 Shanghai RAAS Topical Thrombin Product Portfolios and Specifications
13.11.3 Shanghai RAAS Topical Thrombin Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai RAAS Main Business Overview
13.11.5 Shanghai RAAS Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Topical Thrombin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Topical Thrombin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Based Bovine
Table 4. Major Players of Based Human
Table 5. Major Players of Others
Table 6. Global Topical Thrombin Sales by Type (2018-2023) & (Tons)
Table 7. Global Topical Thrombin Sales Market Share by Type (2018-2023)
Table 8. Global Topical Thrombin Revenue by Type (2018-2023) & ($ million)
Table 9. Global Topical Thrombin Revenue Market Share by Type (2018-2023)
Table 10. Global Topical Thrombin Sale Price by Type (2018-2023) & (US$/Kg)
Table 11. Global Topical Thrombin Sales by Application (2018-2023) & (Tons)
Table 12. Global Topical Thrombin Sales Market Share by Application (2018-2023)
Table 13. Global Topical Thrombin Revenue by Application (2018-2023)
Table 14. Global Topical Thrombin Revenue Market Share by Application (2018-2023)
Table 15. Global Topical Thrombin Sale Price by Application (2018-2023) & (US$/Kg)
Table 16. Global Topical Thrombin Sales by Company (2018-2023) & (Tons)
Table 17. Global Topical Thrombin Sales Market Share by Company (2018-2023)
Table 18. Global Topical Thrombin Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Topical Thrombin Revenue Market Share by Company (2018-2023)
Table 20. Global Topical Thrombin Sale Price by Company (2018-2023) & (US$/Kg)
Table 21. Key Manufacturers Topical Thrombin Producing Area Distribution and Sales Area
Table 22. Players Topical Thrombin Products Offered
Table 23. Topical Thrombin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Topical Thrombin Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global Topical Thrombin Sales Market Share Geographic Region (2018-2023)
Table 28. Global Topical Thrombin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Topical Thrombin Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Topical Thrombin Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global Topical Thrombin Sales Market Share by Country/Region (2018-2023)
Table 32. Global Topical Thrombin Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Topical Thrombin Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Topical Thrombin Sales by Country (2018-2023) & (Tons)
Table 35. Americas Topical Thrombin Sales Market Share by Country (2018-2023)
Table 36. Americas Topical Thrombin Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Topical Thrombin Revenue Market Share by Country (2018-2023)
Table 38. Americas Topical Thrombin Sales by Type (2018-2023) & (Tons)
Table 39. Americas Topical Thrombin Sales by Application (2018-2023) & (Tons)
Table 40. APAC Topical Thrombin Sales by Region (2018-2023) & (Tons)
Table 41. APAC Topical Thrombin Sales Market Share by Region (2018-2023)
Table 42. APAC Topical Thrombin Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Topical Thrombin Revenue Market Share by Region (2018-2023)
Table 44. APAC Topical Thrombin Sales by Type (2018-2023) & (Tons)
Table 45. APAC Topical Thrombin Sales by Application (2018-2023) & (Tons)
Table 46. Europe Topical Thrombin Sales by Country (2018-2023) & (Tons)
Table 47. Europe Topical Thrombin Sales Market Share by Country (2018-2023)
Table 48. Europe Topical Thrombin Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Topical Thrombin Revenue Market Share by Country (2018-2023)
Table 50. Europe Topical Thrombin Sales by Type (2018-2023) & (Tons)
Table 51. Europe Topical Thrombin Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa Topical Thrombin Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa Topical Thrombin Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Topical Thrombin Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Topical Thrombin Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Topical Thrombin Sales by Type (2018-2023) & (Tons)
Table 57. Middle East & Africa Topical Thrombin Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Topical Thrombin
Table 59. Key Market Challenges & Risks of Topical Thrombin
Table 60. Key Industry Trends of Topical Thrombin
Table 61. Topical Thrombin Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Topical Thrombin Distributors List
Table 64. Topical Thrombin Customer List
Table 65. Global Topical Thrombin Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global Topical Thrombin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Topical Thrombin Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas Topical Thrombin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Topical Thrombin Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC Topical Thrombin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Topical Thrombin Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe Topical Thrombin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Topical Thrombin Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa Topical Thrombin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Topical Thrombin Sales Forecast by Type (2024-2029) & (Tons)
Table 76. Global Topical Thrombin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Topical Thrombin Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global Topical Thrombin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Takeda Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 80. Takeda Topical Thrombin Product Portfolios and Specifications
Table 81. Takeda Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 82. Takeda Main Business
Table 83. Takeda Latest Developments
Table 84. Bayer Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 85. Bayer Topical Thrombin Product Portfolios and Specifications
Table 86. Bayer Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 87. Bayer Main Business
Table 88. Bayer Latest Developments
Table 89. CSL Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Topical Thrombin Product Portfolios and Specifications
Table 91. CSL Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 92. CSL Main Business
Table 93. CSL Latest Developments
Table 94. Grifols Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 95. Grifols Topical Thrombin Product Portfolios and Specifications
Table 96. Grifols Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 97. Grifols Main Business
Table 98. Grifols Latest Developments
Table 99. GE Healthcare Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 100. GE Healthcare Topical Thrombin Product Portfolios and Specifications
Table 101. GE Healthcare Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 102. GE Healthcare Main Business
Table 103. GE Healthcare Latest Developments
Table 104. Hualan Biological Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 105. Hualan Biological Topical Thrombin Product Portfolios and Specifications
Table 106. Hualan Biological Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 107. Hualan Biological Main Business
Table 108. Hualan Biological Latest Developments
Table 109. Haematologic Technologies Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 110. Haematologic Technologies Topical Thrombin Product Portfolios and Specifications
Table 111. Haematologic Technologies Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 112. Haematologic Technologies Main Business
Table 113. Haematologic Technologies Latest Developments
Table 114. Pfizer Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 115. Pfizer Topical Thrombin Product Portfolios and Specifications
Table 116. Pfizer Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 117. Pfizer Main Business
Table 118. Pfizer Latest Developments
Table 119. Octapharma Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 120. Octapharma Topical Thrombin Product Portfolios and Specifications
Table 121. Octapharma Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 122. Octapharma Main Business
Table 123. Octapharma Latest Developments
Table 124. Omrix Biopharmaceuticals Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 125. Omrix Biopharmaceuticals Topical Thrombin Product Portfolios and Specifications
Table 126. Omrix Biopharmaceuticals Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 127. Omrix Biopharmaceuticals Main Business
Table 128. Omrix Biopharmaceuticals Latest Developments
Table 129. Shanghai RAAS Basic Information, Topical Thrombin Manufacturing Base, Sales Area and Its Competitors
Table 130. Shanghai RAAS Topical Thrombin Product Portfolios and Specifications
Table 131. Shanghai RAAS Topical Thrombin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 132. Shanghai RAAS Main Business
Table 133. Shanghai RAAS Latest Developments
List of Figures
Figure 1. Picture of Topical Thrombin
Figure 2. Topical Thrombin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Topical Thrombin Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Topical Thrombin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Topical Thrombin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Based Bovine
Figure 10. Product Picture of Based Human
Figure 11. Product Picture of Others
Figure 12. Global Topical Thrombin Sales Market Share by Type in 2022
Figure 13. Global Topical Thrombin Revenue Market Share by Type (2018-2023)
Figure 14. Topical Thrombin Consumed in Hospitals
Figure 15. Global Topical Thrombin Market: Hospitals (2018-2023) & (Tons)
Figure 16. Topical Thrombin Consumed in Diagnostics & Clinics
Figure 17. Global Topical Thrombin Market: Diagnostics & Clinics (2018-2023) & (Tons)
Figure 18. Topical Thrombin Consumed in Academic and Research Institute
Figure 19. Global Topical Thrombin Market: Academic and Research Institute (2018-2023) & (Tons)
Figure 20. Global Topical Thrombin Sales Market Share by Application (2022)
Figure 21. Global Topical Thrombin Revenue Market Share by Application in 2022
Figure 22. Topical Thrombin Sales Market by Company in 2022 (Tons)
Figure 23. Global Topical Thrombin Sales Market Share by Company in 2022
Figure 24. Topical Thrombin Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Topical Thrombin Revenue Market Share by Company in 2022
Figure 26. Global Topical Thrombin Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Topical Thrombin Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Topical Thrombin Sales 2018-2023 (Tons)
Figure 29. Americas Topical Thrombin Revenue 2018-2023 ($ Millions)
Figure 30. APAC Topical Thrombin Sales 2018-2023 (Tons)
Figure 31. APAC Topical Thrombin Revenue 2018-2023 ($ Millions)
Figure 32. Europe Topical Thrombin Sales 2018-2023 (Tons)
Figure 33. Europe Topical Thrombin Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Topical Thrombin Sales 2018-2023 (Tons)
Figure 35. Middle East & Africa Topical Thrombin Revenue 2018-2023 ($ Millions)
Figure 36. Americas Topical Thrombin Sales Market Share by Country in 2022
Figure 37. Americas Topical Thrombin Revenue Market Share by Country in 2022
Figure 38. Americas Topical Thrombin Sales Market Share by Type (2018-2023)
Figure 39. Americas Topical Thrombin Sales Market Share by Application (2018-2023)
Figure 40. United States Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Topical Thrombin Sales Market Share by Region in 2022
Figure 45. APAC Topical Thrombin Revenue Market Share by Regions in 2022
Figure 46. APAC Topical Thrombin Sales Market Share by Type (2018-2023)
Figure 47. APAC Topical Thrombin Sales Market Share by Application (2018-2023)
Figure 48. China Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Topical Thrombin Sales Market Share by Country in 2022
Figure 56. Europe Topical Thrombin Revenue Market Share by Country in 2022
Figure 57. Europe Topical Thrombin Sales Market Share by Type (2018-2023)
Figure 58. Europe Topical Thrombin Sales Market Share by Application (2018-2023)
Figure 59. Germany Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Topical Thrombin Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Topical Thrombin Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Topical Thrombin Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Topical Thrombin Sales Market Share by Application (2018-2023)
Figure 68. Egypt Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Topical Thrombin Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Topical Thrombin in 2022
Figure 74. Manufacturing Process Analysis of Topical Thrombin
Figure 75. Industry Chain Structure of Topical Thrombin
Figure 76. Channels of Distribution
Figure 77. Global Topical Thrombin Sales Market Forecast by Region (2024-2029)
Figure 78. Global Topical Thrombin Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Topical Thrombin Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Topical Thrombin Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Topical Thrombin Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Topical Thrombin Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の局所トロンビン市場予測 2023年-2029年] (コード:LP23DC01886)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の局所トロンビン市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆